2018 annual financial data
Alnylam Pharmaceuticals 2018 Operating margin
Alnylam Pharmaceuticals 2018 operating margin with verified reported values.
Direct answer
Operating margin was -1,087.56%.
Operating income was -814,673,000 USD and net income was -761,497,000 USD.
Operating cash flow was -562,616,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 74,908,000 USD
- Operating income
- -814,673,000 USD
- Net income
- -761,497,000 USD
- Operating cash flow
- -562,616,000 USD